Ascendis Pharma A (ASND) Cash from Discontinued Operations (2021 - 2026)
Ascendis Pharma A's (ASND) quarterly Cash from Discontinued Operations came in at 9039327.16 in Q1 2026, up 39.96% year-on-year from 6458486.62 in Q1 2025, and down 113.27% quarter-over-quarter from 68137206.94 in Q3 2025.
Ascendis Pharma A (ASND) Cash from Discontinued Operations (2021 - 2026) Analysis & Trends
Ascendis Pharma A has disclosed Cash from Discontinued Operations across 6 years of filings, most recently posting 9039327.16 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -59.14 Mn |
| 10 | Ascendis Pharma A | 2.75 Bn | 2.08 Bn | 268.20 Mn | -9.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.04 Mn |
| Mar 31, 2026 | -9.04 Mn |
| Sep 30, 2025 | 68.14 Mn |
| Sep 30, 2025 | 68.14 Mn |
| Jun 30, 2025 | 176.08 Mn |
| Jun 30, 2025 | 176.08 Mn |
| Mar 31, 2025 | -15.06 Mn |
| Mar 31, 2025 | -15.06 Mn |
| Sep 30, 2024 | -61.64 Mn |
| Sep 30, 2024 | -61.64 Mn |
| Jun 30, 2024 | -66.02 Mn |
| Jun 30, 2024 | -66.02 Mn |
| Mar 31, 2024 | -110.35 Mn |
| Mar 31, 2024 | -110.35 Mn |
| Sep 30, 2023 | -135.77 Mn |
| Sep 30, 2023 | -135.77 Mn |
| Jun 30, 2023 | -166.74 Mn |
| Jun 30, 2023 | -166.74 Mn |
| Mar 31, 2023 | -157.83 Mn |
| Mar 31, 2023 | -157.83 Mn |